Maria

Researchers are studying the effects of omega-3 monoglycerides MAG-EPA on cognitive health, specifically targeting people who experience brain foga condition characterized by problems with concentration, memory, confusion, and mental fatigue. Brain fog can result from various causes such as stress, lack of sleep, viral infections like long COVID, hormonal changes, and other medical or lifestyle factors. This research explores whether MAG-EPA can help improve cognitive symptoms in affected individuals. The study has two phases. In Phase 1, eight participants will receive MAG-EPA daily at a dose of 1.5 grams for 8 weeks. If improvement is observed, Phase 2 will include 40 participants randomly assigned to either MAG-EPA or a placebo group receiving sunflower oil daily for 16 weeks. Participants will take three capsules daily and undergo a 28-day washout after treatment. Blood tests will measure Omega-3 levels to monitor adherence and treatment effects. Participants will complete the Brain Fog Scale questionnaire every two weeks throughout the study and follow-up periods to track cognitive health changes. Blood samples will be collected at specific intervals to assess Omega-3 intake. Researchers will also record demographic information and monitor any adverse health events. The total study participation spans up to 22 weeks, including treatment and washout periods, with close monitoring of cognitive function and safety.